Sentiment Trading

IN8bio Inc. has reported promising preclinical results for its cancer treatment, INB-619, which has sparked interest among investors and industry observers.

IN8bio Inc. is a clinical-stage biotech company pioneering cancer therapies using innovative T cell approaches, aiming to revolutionize cancer treatment and provide hope to patients battling the disease.